Stockreport

Analysts' Revenue Estimates For Kymera Therapeutics, Inc. (NASDAQ:KYMR) Are Surging Higher [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF The revenue forecast for this year has experienced a facelift, with analysts now much more optimistic on its sales pipeline. Following the latest upgrade, the 17 analy [Read more]